Arrestins bind ligand-activated, phosphorylated G protein-coupled receptors (GPCRs) and terminate the activation of G proteins. Additionally, nonvisual arrestin/GPCR complex can initiate G proteinindependent intracellular signals through their ability to act as scaffolds that bring other signaling molecules to the internalized GPCR. Like nonvisual arrestins, vertebrate visual arrestin (ARR1) terminates G protein signaling from light-activated, phosphorylated GPCR, rhodopsin. Unlike nonvisual arrestins, its role as a transducer of signaling from internalized rhodopsin has not been reported in the vertebrate retina. Formation of signaling complexes with arrestins often requires recruitment of the endocytic adaptor protein, AP-2. We have previously shown that Lys296 → Glu (K296E), which is a naturally occurring rhodopsin mutation in certain humans diagnosed with autosomal dominant retinitis pigmentosa, causes toxicity through forming a stable complex with ARR1. Here we investigated whether recruitment of AP-2 by the K296E/ARR1 complex plays a role in generating the cell death signal in a transgenic mouse model of retinal degeneration. We measured the binding affinity of ARR1 for AP-2 and found that, although the affinity is much lower than that of the other arrestins, the unusually high concentration of ARR1 in rods would favor this interaction. We further demonstrate that p44, a splice variant of ARR1 that binds light-activated, phosphorylated rhodopsin but lacks the AP-2 binding motif, prevents retinal degeneration and rescues visual function in K296E mice. These results reveal a unique role of ARR1 in a G protein-independent signaling cascade in the vertebrate retina.
Arrestins bind ligand-activated, phosphorylated G protein-coupled receptors (GPCRs) and terminate the activation of G proteins. Additionally, nonvisual arrestin/GPCR complex can initiate G proteinindependent intracellular signals through their ability to act as scaffolds that bring other signaling molecules to the internalized GPCR. Like nonvisual arrestins, vertebrate visual arrestin (ARR1) terminates G protein signaling from light-activated, phosphorylated GPCR, rhodopsin. Unlike nonvisual arrestins, its role as a transducer of signaling from internalized rhodopsin has not been reported in the vertebrate retina. Formation of signaling complexes with arrestins often requires recruitment of the endocytic adaptor protein, AP-2. We have previously shown that Lys296 → Glu (K296E), which is a naturally occurring rhodopsin mutation in certain humans diagnosed with autosomal dominant retinitis pigmentosa, causes toxicity through forming a stable complex with ARR1. Here we investigated whether recruitment of AP-2 by the K296E/ARR1 complex plays a role in generating the cell death signal in a transgenic mouse model of retinal degeneration. We measured the binding affinity of ARR1 for AP-2 and found that, although the affinity is much lower than that of the other arrestins, the unusually high concentration of ARR1 in rods would favor this interaction. We further demonstrate that p44, a splice variant of ARR1 that binds light-activated, phosphorylated rhodopsin but lacks the AP-2 binding motif, prevents retinal degeneration and rescues visual function in K296E mice. These results reveal a unique role of ARR1 in a G protein-independent signaling cascade in the vertebrate retina.
A utosomal dominant retinitis pigmentosa (ADRP) is a blinding disorder in humans that is commonly caused by rhodopsin mutations (1) . Some of these mutations constrain the molecule in an active conformation, and it was previously thought that the constitutive activation of transducin, the visual G protein, underlies the pathogenic mechanism. However, a study using transgenic mice that express such an activating mutation, Lys296 → Glu (K296E), showed that it is deactivated by phosphorylation and arrestin binding (2) . How this class of rhodopsin mutations leads to death of vertebrate rods remains unclear. In Drosophila, stable rhodopsin/arrestin complexes were found to be cytotoxic (3, 4) through recruitment of adaptor protein, AP-2 (5), a key endocytic protein, by visual arrestin (DroArr2), followed by accumulation of endocytosed rhodopin in late endosomes (6) . Like many other G protein-coupled receptors, endocytosis of light activated Drosophila rhodopsin is part of normal cell physiology. In contrast, ARR1-mediated internalization has not been observed for vertebrate rhodopsin in the intact retina. Drosophila phototransduction also diverges substantially from that of vertebrates in terms of utilization of G protein Gq, which couples to phospholipase C. Although this signaling cascade appears to underlie circadian entrainment mediated by a class of intrinsically photosensitive retinal ganglion cells (7) , vertebrate rods and cones use transducin, which belongs to the Gi class of G proteins and activates a cyclic GMP phosphodiesterase, PDE6 (8, 9) . Furthermore, Drosophila phototransduction occurs in the rhabdomeres, which are contiguous with other cellular compartments where rhodopsin/arrestin complex has direct access to the endocytic machinery. In contrast, vertebrate rhodopsin is synthesized in the inner segment and transported to the membranous outer segment compartment, which is separated from the rest of the cell by a narrow cilium. Once rhodopsin is incorporated into outer segment discs, its concentration there remains constant (10) . Based on the divergence between vertebrate and invertebrate phototransduction, as well as the differences in the architecture of the photoreceptor cell, a conserved pathogenic mechanism of rhodopsin/arrestin complex cannot be assumed.
We used transgenic mice that express K296E to investigate whether AP-2 recruitment by the rhodopsin/arrestin complex leads to the cell death pathway in the vertebrate retina. We show that ARR1 lacks a high-affinity motif for binding the clathrin adaptor protein AP-2, but the high concentration of ARR1 in rods can still drive this interaction. This possibility is supported by biochemical and immunocytochemical evidence that the K296E/ ARR1 complex recruits AP-2 and clathrin. Importantly, we show that retinal morphology and function is preserved when K296E is expressed with a naturally occurring ARR1 splice variant, p44, which deactivates photolyzed rhodopsin normally but lacks the AP-2 binding element. This rescue is long lasting, in the time frame up to 2 y. Together, these results provide unique evidence for a role for vertebrate ARR1 in a signaling pathway distinct from its known function in quenching phototransduction.
Results
We have previously shown that stable rhodopsin/arrestin complex is toxic to the mammalian retina in a cell death pathway that is conserved from flies to mice (11) . To see whether endocytosis of K296E/ARR1 is involved in generating an apoptotic signaling pathway, we investigated the ability of ARR1 to bind AP-2, the adaptor protein central to coated pit formation (12, 13) . The AP-2 complex is composed of two large subunits (α2 and β2) and two smaller subunits (μ2 and σ2). The appendage domains of α2 and β2 are found at the end of flexible linkers that extend from the core of the adaptor complex (13) . These appendages recruit interacting partners from the cytosol and thereby facilitate their concentration at sites of coated pit formation (14) . Nonvisual arrestins and DroArr2 interact specifically with the β2 appendage of AP-2 (5, 15). The molecular basis of this interaction can be seen in a crystal structure, where the contact sites were identified to be AspxxPhexxPhexxxArg (DxxFxxFxxxR), where x denotes other amino acids (14) . A closer look at the amino acid alignment of these residues shows that the binding motif is largely conserved in DroArr2 and vertebrate nonvisual arrestins (Fig. 1A) . However, a critical residue in AP-2 interaction, R384, is not conserved in mammalian ARR1 (Fig. 1B) . Previous mutagenesis studies indicate that this is a key residue in the interaction between nonvisual arrestins and AP-2 (15) (16) (17) . To quantify the effect of the difference in amino acid at position 384 for AP-2 binding, we synthesized spin-labeled peptides that contain the binding motif for AP-2 in various arrestins and measured their binding affinity for AP-2 using electron paramagnetic resonance. This assay is based upon the change in line shape and the concomitant loss in signal amplitude that occurs when the small peptides become ordered and exhibit reduced tumbling upon binding to AP-2. The most pronounced loss in amplitude was observed for nonvisual arrestin (Fig. 1C) , indicating that this peptide exhibits the strongest binding. Quantification of the spectral components of the bound and unbound states yielded a K d of 9 μM. This low micromolar binding affinity is consistent with previous reports (14) . In contrast, the binding for ARR1 was weaker with a K d of 306 μM. This loss in binding affinity was almost entirely compensated by the Asn384 → Arg (N384R) mutation, which effectively converted the conserved binding sites of ARR1 to DroArr2 (Fig. 1A) . These data show that a large difference in binding affinity exists between ARR1 and the other arrestins for AP-2. However, because the concentration of ARR1 in rods is estimated to be >2 mM (18, 19) compared with the ubiquitously expressed arrestin-2 and -3 that are expressed at ≤0.2 μM (20), binding between ARR1 and AP-2 could occur in vivo.
K296E/ARR1 Complex Recruits Endocytic Proteins to the Rod Outer
Segments. Rod cells express two splice variants of ARR1: the abundant, full-length 48-kDa form that is nearly stoichiometric with rhodopsin and a less abundant, truncated variant called p44 in bovine rods (21, 22) . By expressing each singly in the ARR1 −/− rods in mice, we have previously shown that both are equally efficient in deactivating photolyzed, phosphorylated rhodopsin (R*-P) (23) . Interestingly, the p44 ARR1 1-370A is truncated at the carboxyl terminus and does not possess the AP-2 binding motif shown in Fig. 1A . To see whether K296E/ARR1 interacts with endocytic proteins in the rod cell, Western blots were performed on washed rod outer segments (ROSs) isolated from K296E, K296E-negative, wild-type C57, and K296E/p44 ARR1−/− retinas. Washed ROSs consists of membrane proteins, of which >90% is rhodopsin (24) . Both endophilin and AP-2 are key endocytic proteins associated with clathrin-coated pits (25) . If endophilin is recruited to the K296E/arrestin complex, then its level should be increased in washed ROSs. A representative Western blot is shown in Fig. 2A . G-protein subunit Gβ5 served as a loading control. Gβ5 has two splice variants: the long form (Gβ5L) is localized to the ROS, whereas the short form (Gβ5S) is expressed in the inner segment and in other retinal cells and is indicative of contamination from these sources (26) . Quantified values of the endophilin signal normalized to that of Gβ5L are shown in Fig.  2B . Indeed, the amount of endophilin appeared to be increased more than 10-fold in K296E ROSs compared with the control samples. This trend was reversed when K296E retinas expressed p44 instead of ARR1.
In addition to the Western blot, colocalization of K296E with endocytic markers in retinal sections was performed. Consistent with previous observations, the majority of ARR1 resides in the inner segment compartments in the dark adapted WT retina but is recruited to the ROSs by forming a complex with K296E (Fig.  3A) . Staining of retinal sections with an antibody against AP-2 and clathrin showed low levels in the ROSs of WT sections, but more abundant in the ROSs of K296E retina. This pattern was reversed in the K296E/p44 ARR1−/− sections even though p44 was present in the ROSs (Fig. 3A) . These results are in good agreement with the Western data of increased levels of endophilin in the ROSs of K296E mice. Internalization of ligandactivated G protein-coupled receptors (GPCRs) into endocytic vesicles is typically visualized as puncta near the plasma membrane using immunofluorescent labeling of AP-2 or clathrin (27, 28) . Puncta that resembled endocytic vesicles can be seen in the plasma membrane surrounding the nucleus and inner segment (Fig. 3B) , consistent with previous observations for the primary sites of endocytosis in rod cells (29, 30) . In the WT retina, rhodopsin is predominantly localized to the ROSs and little rhodopsin immunoreactivity is typically seen surrounding the plasma membrane at the outer nuclear layer (Fig. 3B, WT) . However, association of K296E with ARR1 also causes some K296E molecules to be mislocalized to this site (11) . Here rhodopsin immunoreactivity shows partial overlap with AP-2 and clathrinpositive puncta (Fig. 3B, K296E ). Staining using antibody to endophilin yielded similar results (Fig. S1 ). These results suggest that K296E/ARR1 complex recruits endocytic proteins through the carboxyl domain of ARR1 that contains the AP-2 binding (A) Western blot of washed outer segments from the indicated mice probed with an antibody against endophilin. Gβ5L served as a loading control for the amount of ROSs, whereas Gβ5S signal arises from non-ROS sources. Localization of Gβ5L in retinal sections show similar distribution to ROSs in WT and K296E mice (Fig. S2) . The blot is representative of three independent experiments. (B) Signals derived from endophilin and Gβ5L were quantified using the LI-COR Odyssey software package. The value obtained for endophilin was normalized to that of Gβ5L (mean ± SEM). The relative amount of K296E + sample is significantly different from that of control, which represents combined K296E − and C57 samples (two-tailed Student t test, P < 0.0002).
motif. Together, the immunocytochemistry and Western blot experiments are consistent with a role of K296E/ARR1 in the recruitment of endocytic proteins in rod cells.
Rescue of Retinal Degeneration in K296E/p44
ARR1−/− Retinas. If AP-2 recruitment by ARR1 mediates the retinal degeneration caused by K296E, then a prediction can be made that cell death would be prevented in ARR1
−/− rods that express p44. Furthermore, R* inactivation would proceed normally in these rods. To test these predictions, K296E was introduced into the p44 ARR1−/− background and compared with various control mouse lines. All mice were born and raised in darkness to prevent any associated lightdependent retinal degeneration. Retinal morphology from a 10-wk-old K296E mouse showed thinning of the outer nuclear layer (ONL), indicating loss of rods compared with transgene-negative littermates (Fig. 4 A and B) . Crossing K296E into the ARR1 −/− background resulted in decreased ONL thickness as well as marked shortening of the outer segments, although the toxic K296E/ARR1 complex would not be formed (Fig. 4C) . We attributed the degeneration of K296E ARR1−/− retina to the unmasking of the catalytic activity of K296E when ARR1 is not present, creating a source of "equivalent light." It is known that chronic light exposure would lead to a long-term adaptive behavior called "photostasis" (31, 32) , whereby the outer segment becomes shortened to decrease the rate of photon catch. In support of this mechanism, retinal degeneration in K296E ARR1−/− mice was prevented in the rod transducin knockout (GNAT1 −/− ) background (Fig. 4D, see also ref. 11) . Consistent with our prediction, the retinal morphology was noticeably improved in littermates of K296E ARR1−/− that expressed p44: the outer segment length and ONL thickness were similar to that of K296E-negative littermates (Fig. 4, compare E with A) . The degree of retinal degeneration can be quantified by measuring the thickness of the ONL across the entire span of the retina, which showed a ∼30% reduction in the thickness of K296E retinas compared with that of transgene-negative littermates. This reduction was statistically significant over the central region of the retina (Fig. 4F asterisks, P < 0.01). Retinal degeneration was not observed in K296E/ p44 ARR1−/− retinas; the ONL thickness was comparable to that of transgene-negative control retinas (Fig. 4F) . Thus, p44 appears to protect the K296E retina from photostasis, while circumventing the toxic effects of the rhodopsin/ARR1 complex.
Recovery of Visual Function in K296E/p44
ARR1−/− Mice. A key distinction between rescue of K296E ARR1−/− retina by transgenic expression of p44 (Fig. 4E) and by GNAT1 −/− (Fig. 4D) is that p44 should provide functional rescue, whereas GNAT1 −/− cannot, due to the absence of rod transducin. We used electroretinography (ERG) on 10-wk-old mice to investigate whether recovery of visual function accompanied morphologic improvement in the K296E/ p44 ARR1−/− retina. To do so, there should be sufficient quantities of p44 to bind K296E and light-activated rhodopsin, R*. We have previously determined the amount of K296E protein to be 5% of total rhodopsin pool, corresponding to approximately 25 pmol per retina (33) . The amount of p44 was estimated to be 12% of endogenous ARR1, or approximately 50 pmol (18) . This expression level, albeit low, is nevertheless expected to restore rapid recovery of the light response (18) . The ERG a-wave reflects the summed responses from the photoreceptor cells, whereas the b-wave corresponds to responses from the bipolar cells. Consistent with the loss of rods, K296E mice exhibited an attenuated ERG and an increased light threshold compared with their transgene-negative littermates. In contrast, the K296E/p44 ARR1−/− mice showed responses similar to the control mice (Fig. 5A) . Quantification of the amplitudes of the a-and b-wave is shown in Fig. 5 B and C, respectively. Both were significantly reduced in the K296E mice (P < 0.01), but not in K296E/p44 ARR1−/− mice, which showed similar a-wave responses and even increased b-wave responses compared with the transgene-negative mice. Thus, p44 restores visual function to K296E mice in addition to preventing K296E-induced retinal degeneration. Because p44 is functionally equivalent to full-length ARR1 in binding R* but lacks the AP-2 binding sequences, this result strongly implicates AP-2 recruitment by K296E/ARR1 complex in the cell death pathway.
Long-Lasting Rescuing Effect of p44. Older animals were examined for the long-term effectiveness of p44 in preventing retinal degeneration in K296E mice. In a one-y-old K296E mouse, the ONL progressively thinned to three to four cell layers; the outer segment shortened as well (Fig. 6A) . Remarkably, the expression of p44 was effective in prolonging photoreceptor cell survival in K296E mice even after 18 and 24 mo (Fig. 6 B and C, respectively). ERGs were performed to test whether retinal function is correspondingly retained. Fig. 6D shows that this was indeed the case. As expected from the degree of degeneration, responses from one-y-old K296E showed a further decrease from Arrestin is predominantly present in the IS/ONL compartments in the darkadapted WT retina. However, it extends to the OS in the presence of K296E. The splice variant p44 is similarly recruited to the ROS. In the WT retina, the majority of AP-2 and clathrin immunoreactivity is seen in the IS and ONL. However, in the K296E retina labeling is seen to extend to the OS, following that of ARR1. The altered distribution pattern of AP-2 and clathrin is reversed in the K296E/p44 ARR1−/− retina (Right). (B) WT and K296E retinal sections at the IS/ONL junction. AP-2 and clathrin are labeled in green (Left) and rhodopsin in red (Center). Merged image is shown (Right). Sections in A were counterstained with DAPI to visualize nuclei (blue). These are representative of independent experiments repeated four or more times. [Scale bar, 25 μm (A) and 10 μm (B).] 10 wk. In contrast, a two-y-old K296E/p44 ARR1−/− mouse showed robust responses, indicating that visual function was maintained over long periods of time. These data provide strong genetic evidence that AP-2 recruitment by the K296E/ARR1 complex plays a role in K296E-induced retinal degeneration.
Discussion
Rhodopsin consists of the opsin protein moiety and the 11-cis retinal chromophore, which is attached to residue K296 through a protonated Schiff base linkage (34) . Following photon absorption, the Schiff base linkage is hydrolyzed and all-trans retinal dissociates from opsin, and the apoprotein molecule is constrained to an inactive conformation by a salt bridge that is formed by K296 and E113. The K296E mutation destroys the retinal attachment site as well as the salt bridge (35, 36) . Consequently, K296E does not bind 11-cis retinal, is insensitive to light, and is locked in an active conformation that is a substrate for phosphorylation and ARR1 binding (37) . Based on our results, we propose a model that recruitment of AP-2 by K296E/ ARR1 leads to rod cell death (Fig. 7A) . When the K296E/ARR1 complex formation is prevented in the ARR1 −/− background, K296E in turn activates tranducin and induces cell death through a G protein-dependent pathway (Fig. 7B) . This mechanism of cell death is circumvented in the transducin knockout background (Fig. 4D) (11) . A full morphologic and functional rescue occurs when p44 is expressed. In this scenario, K296E is silenced and recovery of the light response is restored (Fig. 7C) . This rescuing effect is observed only in the ARR1 −/− background, due to the dominant effect of the more abundant full-length ARR1. Interestingly, the b-wave of K296E/p44 ARR1−/− retinas tends to be larger than in control mice, suggesting an additional synaptic phenotype. The mechanism that underlies this phenotype will be the subject of future investigations.
Each rod cell contains 3 mM rhodopsin and nearly equimolar ARR1 (18, 19) . Upon bright light exposure, millimolar concentrations of R*/ARR1 complex would be formed. What may prevent this complex from causing cell death? First, sequestration of these complexes to the outer segment and away from the endocytic machinery in the cell body may have evolved to ensure that the potentially toxic product of phototransduction does not interfere with normal endocytosis. Second, the low affinity between ARR1 and AP-2 and the transient lifetime of meta II (MII) rhodopsin may have evolved as a protective mechanism against formation of excessive amount of R*/arrestin complex in the inner segment for those newly synthesized rhodopsin molecules that are en route to the outer segment. Third, residues 375-377 of ARR1, which overlap with the AP-2 binding element (Phe-Val-Phe in bovine), participate in a network of intramolecular interactions that are responsible for stabilizing the basal conformation of ARR1 (38); thus, the AP-2 interacting element is masked, whereas ARR1 + (▲, n = 3), K296E/p44 ARR1−/− (•, n = 6). Groups were compared by ANOVA followed by Tukey's honestly significant difference (HSD). *P < 0.01, significant difference. S, superior; I, inferior. exists in the latent, inactive conformation but exposed upon receptor binding (27) . In contrast to wild-type rhodopsin, which is effectively transported to the outer segment discs, K296E mislocalizes to the plasma membrane through association with ARR1 (11) . Although our data show that K296E recruited endocytic proteins to the outer segment, we hypothesize that toxicity of K296E arises primarily from the formation of stable K296E/ARR1 complex in the cell body where it has access to other signaling molecules for execution of the cell death cascade. Degradation of these internalized complexes may explain the discrepancy between K296E transcript level (25%) (2) and protein level (5%) (33) . Alternatively, the K296E/ARR1 complex may cause cell death by depleting endocytic proteins and disrupting normal endocytosis. However, the partial overlap of AP-2 and clathrin at the ONL (Fig. 3B) suggests that there may be sufficient levels of unbound endocytic proteins.
Rhodopsin mislocalization also occurs in a different class of naturally occurring, disease-causing mutations at its carboxyl terminus (39) (40) (41) . These mutants form a visual pigment with 11-cis retinal and activate transducin in a light-dependent manner (42, 43) . Therefore, they could potentially generate elevated levels of R*/ARR1 complex in the inner segment (IS)/ONL compartments upon light exposure. We investigated this possibility in a transgenic mouse line that expressed Gln334 → stop (Q344ter). We found that Q344ter is a substrate for light-dependent phosphorylation in the IS/ONL compartments, but in this case, preventing formation of rhodopsin/arrestin complex by raising the mice in darkness had little effect on retinal degeneration (39) . Rhodopsin mislocalization also occurs when its transport machinery is defective, such as in the case of functional loss of kinesin-2, a major motor for anterograde transport (44) . In this disease model, neither rhodopsin/arrestin complex nor light activation were necessary for cell loss (45) . What could be the explanation for the lack of effect by these mislocalized rhodopsins? A major difference between K296E and these other models is the stability of the K296E/ARR1 complex: because K296E does not bind 11-cis retinal and exists in an active conformation independent of light, it can be phosphorylated and form a stable complex with ARR1 as soon as it is synthesized. In the case of mislocalized Q344ter or wild-type rhodopsin in kinesin-2 loss of function, ARR1 will dissociate from opsin after all-trans retinal is hydrolyzed and released (MII decay). Thus, despite mistrafficking of these rhodopsin molecules, there may not be sufficient levels of R*/ARR1 complex formed in the IS/ ONL to recruit AP-2.
Previous cell culture experiments using ADRP-associated rhodopsin Arg135 → Gly (R135G), Arg135 → Leu (R135L), and Arg135 → Trp (R135W) showed that these mutants were substrates for phosphorylation and arrestin binding in vitro (46) , and colocalized with visual arrestin (ARR1) in endocytic compartments when they were cotransfected into HEK cells (47) . Although these results suggest a role of endocytosis in the toxicity of the vertebrate rhodopsin/arrestin complex, the in vitro system has several caveats. First, it was noted that, depending on expression level, R135 mutants can already appear in endosomes when transfected alone; this behavior was not observed for K296E, which was primarily targeted to the plasma membrane in HEK cells (47) . Second, R135L was phosphorylated by an endogenous kinase expressed by the cultured cells, which is not the native Gprotein receptor kinase 1 (GRK1) that phosphorylates rhodopsin in photoreceptors. This may be of significance inasmuch as the sites and extent of rhodopsin phosphorylation affect arrestin binding (48) (49) (50) . Third, whether ARR1 interacts with endocytic proteins depends on their binding affinity and the concentration of the reactants. Our results show that millimolar concentration of ARR1 is required to drive this interaction, whereas a much lower concentration of nonvisual arrestin would be needed. In this regard, it is possible that nonvisual arrestins are involved in the toxicity of the R135 mutants expressed in cultured cells. Differences in the pathogenic mechanisms of R135 mutants and K296E warrant further investigation.
Mutations yielding constitutively active GPCRs have been seen in many different diseases (51, 52) . The ability of p44 to Model for the role of ARR1 in K296E-induced rod photoreceptor cell death. (A) K296E in an active conformation is highly phosphorylated by rhodopsin kinase and is bound to ARR1. AP-2 is recruited to K296E/ARR1 complexes, which are then targeted to clathrin-coated vesicles. Through recruitment of other signaling molecules to these clathrin-coated vesicles, a cell death signal is generated. (B) In the ARR1 knockout background, K296E constitutively activates transducin, which then leads to cell death. (C) The constitutive activity of K296E is quenched by p44. Because p44 does not contain the AP-2 binding domain, endocytosis does not occur and the cell death signal is not generated.
restore visual function and prevent cell loss caused by K296E has implications for therapy where a combination of approaches to overexpress p44 and knockdown K296E and ARR1 may be more effective than any single approach alone.
Materials and Methods
K296E transgenic mice were obtained from T. Li (National Institutes of Health). These mice and a transgenic line that expressed an ARR1 splice variant, p44 (23) , were both bred with ARR1 knockout mice to obtain K296E ARR1−/− and p44 ARR1−/− mice, respectively. These mice were then bred together to obtain K296E/p44 ARR1−/− mice and their complement negative controls. All mice were maintained on a C57BL6/J background and dark reared as to prevent any associated light-dependent retinal degeneration. Additional details on materials and methods are provided in SI Materials and Methods.
